| P50 | author | Andrew V Caprariello | Q57459369 |
| P2093 | author name string | R H Miller | |
| | S M Selkirk | |
| P2860 | cites work | Transcription start regions in the human genome are favored targets for MLV integration | Q29618456 |
| | HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 |
| | The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs | Q31857129 |
| | Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors | Q34032399 |
| | The foamy viruses | Q34069917 |
| | Foamy virus vector integration sites in normal human cells | Q34334976 |
| | Replication of primate foamy viruses in natural and experimental hosts. | Q35196141 |
| | Human infection with foamy viruses. | Q35196145 |
| | Foamy-virus-mediated gene transfer to canine repopulating cells | Q35615750 |
| | Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors | Q36954062 |
| | Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. | Q39878092 |
| | Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes. | Q40468040 |
| | Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo | Q40682749 |
| | Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: a potential for the treatment of neurological diseases | Q45448749 |
| | Improved foamy virus vectors with minimal viral sequences | Q45730940 |
| | Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses | Q45771507 |
| | Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans | Q45786021 |
| | A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency | Q45857796 |
| | Foamy virus vectors | Q70792195 |
| P433 | issue | 3 | |
| P921 | main subject | vector-borne disease | Q2083837 |
| P304 | page(s) | 448-452 | |
| P577 | publication date | 2008-12-04 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Foamy virus as a gene transfer vector to the central nervous system | |
| P478 | volume | 16 | |